Currently, out of the existing stock ratings of Joseph Munda - 14 which are a Buy (87.5%), 2 which are a Hold (12.5%)

Joseph Munda

Work Performance Price Targets & Ratings Chart

Analyst Joseph Munda works at FIRST ANALYSIS and is covering Healthcare, Industrials sectors with 37 price targets and ratings displayed on 5 stocks.

Joseph Munda's average stock forecast success ratio is 89.33% with an average time for price targets to be met of 540.4 days.

Most recent stock forecast was given on NEO, NeoGenomics at 28-Feb-2020.

Wall Street Analyst Joseph Munda

Analyst best performing recommendations are on NEO (NEOGENOMICS).
The best stock recommendation documented was for NEO (NEOGENOMICS) at 10/24/2018. The price target of $18 was fulfilled within 7 days with a profit of $3.59 (24.91%) receiving and performance score of 35.59.

Average potential price target upside

ANIK Anika Therapeutics LMAT LeMaitre Vascular NEO NeoGenomics ILMN SMED Sharps Compliance

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

24

$5.31 (28.41%)

1 months 19 days ago

7/9 (77.78%)

$3.56 (10.76%)

104

Hold

35

$16.37 (87.87%)

55

1 years 6 months 23 days ago

0/2 (0%)

$12.77 (40.00%)

Hold

46

$27.31 (146.12%)

46

1 years 10 months 15 days ago

0/2 (0%)

$5.38 (13.25%)

Buy

65

$46.31 (247.78%)

54

3 years 8 months 23 days ago

4/5 (80%)

$5.19 (12.48%)

25

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Joseph Munda?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart